Molecular glues targeting protein degradation pathways for drug discovery-Reference-Cited by-同舟云学术

Molecular glues targeting protein degradation pathways for drug discovery

Published:2022-01 Issue:3 Volume:14 Page:135-137
ISSN:1756-8919
Container-title:Future Medicinal Chemistry
language:en
Short-container-title:Future Medicinal Chemistry

Author:

Ren Changyu¹,Gan Xiaohong¹,Zhou Houfeng¹,Li Jinqi²,Zhang Jifa¹³^ORCID

Affiliation:

1. Department of Pharmacy, Chengdu Fifth People's Hospital, Chengdu, Sichuan, 611130, China

2. Department of Pharmacy, Personalized Drug Therapy Key Laboratory, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan, 610072, China

3. State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China

Funder

Health Commission of Sichuan Province

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.future-science.com/doi/pdf/10.4155/fmc-2021-0229

Reference18 articles.

1. Lock-and-key motif as a concept for designing affinity adsorbents for protein purification

2. “Dual-Key-and-Lock” Ruthenium Complex Probe for Lysosomal Formaldehyde in Cancer Cells and Tumors

3. Targeting Lysosomal Degradation Pathways: New Strategies and Techniques for Drug Discovery

4. Development of targeted protein degradation therapeutics

5. Degradation of proteins by PROTACs and other strategies

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complexity‐to‐Diversity and Pseudo‐Natural Product Strategies as Powerful Platforms for Deciphering Next‐Generation Therapeutics;ChemMedChem;2023-06-12

2. Research progress of anticancer drugs targeting CDK12;RSC Medicinal Chemistry;2023